RA Capital Management - VIRIDIAN THERAPEUTICS INC ownership

VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 27 filers reported holding VIRIDIAN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
RA Capital Management ownership history of VIRIDIAN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$30,801,892
-35.5%
2,007,9460.0%0.61%
-32.8%
Q2 2023$47,769,035
-6.5%
2,007,9460.0%0.90%
-22.0%
Q1 2023$51,082,146
+98.7%
2,007,946
+128.2%
1.16%
+121.9%
Q4 2022$25,704,800
+42.4%
880,0000.0%0.52%
+35.3%
Q3 2022$18,049,000
+106070.6%
880,000
+85006.4%
0.38%
Q3 2021$17,000
-99.7%
1,034
-99.7%
0.00%
-100.0%
Q2 2021$5,712,000
+9.4%
312,3280.0%0.09%
+16.5%
Q1 2021$5,219,000312,3280.08%
Other shareholders
VIRIDIAN THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 859,910$15,728,0003.91%
Ghost Tree Capital, LLC 350,000$6,402,0001.76%
COMMODORE CAPITAL LP 186,405$3,409,0001.19%
Atlas Venture Advisors, Inc. 209,505$3,832,0000.40%
Fairmount Funds Management LLC 35,092$642,0000.26%
BVF INC/IL 350,081$6,403,0000.24%
SILVERARC CAPITAL MANAGEMENT, LLC 28,399$519,0000.23%
Cormorant Asset Management, LP 342,962$6,273,0000.21%
Perceptive Advisors 1,589,012$29,062,0000.19%
RA Capital Management 312,328$5,712,0000.09%
View complete list of VIRIDIAN THERAPEUTICS INC shareholders